• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renal transport of urate during diuretic-induced hypouricemia.

作者信息

Reese O G, Steele T H

出版信息

Am J Med. 1976 Jun;60(7):973-9. doi: 10.1016/0002-9343(76)90569-6.

DOI:10.1016/0002-9343(76)90569-6
PMID:937359
Abstract

The effect of two weeks administration of a uricosuric diuretic (SKF-62698) on renal urate handling has been examined in 11 normal men. Plasma urate concentrations had declined by more than 60 per cent after two weeks. Urate excretion per unit of glomerular filtration rate and urate clearance (Curate) per unit of glomerular filtration rate were increased after the administration of SKF-62698. The importance of intact tubular secretion of urate in producing these changes was assessed by administering pyrazinamide, an agent that curtails urate secretion, to each participant. The decrements in urate excretion and clearance produced by pyrazinamide both increased significantly, whereas the residual urate excretion rates and clearances not suppressible by pyrazinamide were only minimally altered by SKF-62698 treatment. These results suggest that the excretion of secreted urate was enhanced by prolonged administration of SKF-62698, probably secondary to the inhibition of postsecretory urate reabsorption. In addition, because the nonsuppressible urate excretion did not decline despite a 63 per cent reduction in the plasma urate, it is likely that the reabsorption of filtered urate also was impaired by SKF-62698.

摘要

相似文献

1
Renal transport of urate during diuretic-induced hypouricemia.
Am J Med. 1976 Jun;60(7):973-9. doi: 10.1016/0002-9343(76)90569-6.
2
Diuretic-induced uricosuria: interaction with pyrazinoate transport in man.利尿剂诱导的尿酸尿症:与人体中吡嗪酸盐转运的相互作用。
J Pharmacol Exp Ther. 1977 Jan;200(1):58-64.
3
The effects of ticrynafen in the rat.替可瑞尼芬对大鼠的影响。
Res Commun Chem Pathol Pharmacol. 1979 Jul;25(1):53-63.
4
Mechanism of the uricosuric activity of ticrynafen.
Nephron. 1979;23 Suppl 1:33-7. doi: 10.1159/000181665.
5
The renal handling of tienilic acid (ticrynafen), a new diuretic with uricosuric properties.
Nephron. 1979;23 Suppl 1:7-14. doi: 10.1159/000181661.
6
Metabolic effects in man of tienilic acid, a new diuretic with uricosuric properties.
Nephron. 1978;20(1):54-64. doi: 10.1159/000184854.
7
The metabolic effects of tienilic acid, a new diuretic with uricosuric properties in man and dog.
Adv Exp Med Biol. 1977;76B:334-41. doi: 10.1007/978-1-4684-3285-5_50.
8
Nature of the uricosuric effect of tienilic acid, a new diuretic.新型利尿剂替尼酸促尿酸排泄作用的性质
Kidney Int. 1977 Aug;12(2):104-14. doi: 10.1038/ki.1977.87.
9
Origins of the uricosuric response.促尿酸排泄反应的起源。
J Clin Invest. 1973 Jun;52(6):1368-75. doi: 10.1172/JCI107309.
10
Insulin-dependent diabetes and renal hypouricemia.胰岛素依赖型糖尿病与肾性低尿酸血症。
Nephron. 1991;59(1):21-6. doi: 10.1159/000186512.

引用本文的文献

1
Urate Handling in the Human Body.人体中的尿酸处理
Curr Rheumatol Rep. 2016 Jun;18(6):34. doi: 10.1007/s11926-016-0587-7.
2
Understanding the dose-response relationship of allopurinol: predicting the optimal dosage.了解别嘌醇的剂量-反应关系:预测最佳剂量。
Br J Clin Pharmacol. 2013 Dec;76(6):932-8. doi: 10.1111/bcp.12126.
3
Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.在正常受试者中长期口服别嘌醇和氢氯噻嗪期间二者的相互作用。I. 尿酸动力学
Clin Investig. 1994 Dec;72(12):1071-5. doi: 10.1007/BF00577758.
4
Acute reversible renal impairment produced by a uricosuric diuretic.一种尿酸排泄利尿药引起的急性可逆性肾功能损害。
West J Med. 1980 Nov;133(5):444-6.
5
The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.无症状性高尿酸血症的风险及促尿酸排泄利尿剂的使用。
Drugs. 1981 Mar;21(3):220-5. doi: 10.2165/00003495-198121030-00003.
6
Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.替尼酸和氨氯吡咪对健康志愿者及肾功能正常的高血压患者的影响。
Br J Clin Pharmacol. 1980 Oct;10(4):345-51. doi: 10.1111/j.1365-2125.1980.tb01770.x.
7
Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function.在高尿酸血症、高血压患者中进行的替尼酸多中心对照试验,并对肝功能进行强化监测。
Br J Clin Pharmacol. 1983 May;15(5):513-8. doi: 10.1111/j.1365-2125.1983.tb02084.x.
8
Uric acid, diuretics and the kidney.尿酸、利尿剂与肾脏。
West J Med. 1978 Nov;129(5):407-11.
9
Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients.
Eur J Clin Pharmacol. 1979 Nov;16(5):319-22. doi: 10.1007/BF00605628.